logo

GH

Guardant Health·NASDAQ
--
--(--)
--
--(--)

GH fundamentals

Guardant Health (GH) expects to report earnings on Feb 19, 2026, with estimated revenue of 271.82M (YoY +34.69%), and EPS at -0.763 (YoY +15.22%).
Revenue estimate / YoY
271.82M
+34.69%
EPS estimate / YoY
-0.763
+15.22%
Report date
Feb 19, 2026
Earnings Call
4:30 PM on Feb 19, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

GH has released its 2025 Q3 earnings report, with revenue of 265.20M, reflecting a YoY change of 38.50%, and net profit of -92.72M, showing a YoY change of 13.95%. The Sankey diagram below clearly presents GH's revenue sources and cost distribution.

Key Indicators

Guardant Health (GH) key financial stats and ratios, covering profitability, financial health, and leverage.
Guardant Health (GH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Guardant Health (GH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Guardant Health (GH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Guardant Health (GH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Guardant Health (GH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield